Emerging Role of Immune Checkpoint Blockade in the Treatment of Refractory/Relapsed Hodgkin and Non-Hodgkin Lymphoma

 
FRIDAY, NOVEMBER 30, 2018
7:30 AM – 9:00 AM

Location

SAN DIEGO CONVENTION CENTER
111 W Harbor Drive
San Diego, CA 92011
Meeting Room: rooms 1AB, upper level

 

REGISTER NOW!
Already Registered?
SIGN IN

 
 

This symposium is preceding the 60th ASH Annual Meeting and Exposition

 

WEBCAST DATE

FRIDAY, NOVEMBER 30, 2018

10:30 AM Eastern    9:30 AM Central    8:30 AM Mountain    7:30 AM Pacific

Add to Calendar 11/30/2018 10:30 AM 11/30/2018 12:00 PM America/New_York Emerging Role of Immune Checkpoint Blockade in the Treatment of Refractory/Relapsed Hodgkin and Non-Hodgkin Lymphoma Emerging Role of Immune Checkpoint Blockade in the Treatment of Refractory/Relapsed Hodgkin and Non-Hodgkin Lymphoma Live Simulcast Med Learning Group info@medlearninggroup.com false MM/DD/YYYY atZOdzeAgzXtBkKLjmOo27579

 

FACULTY

Philippe Armand, MD, PhD
Senior Physician
Director, Clinical Research, Lymphoma Program
Harold and Virginia Lash Endowed Chair in Lymphoma Research
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Justin Kline, MD
Assistant Professor of Medicine
Section of Hematology/Oncology
Comprehensive Cancer Center, Committee on Immunology
University of Chicago Medicine
Chicago, IL

TARGET AUDIENCE

This CME initiative is designed to meet the educational needs of hematologist-oncologists involved in the treatment of adults with cHL and NHL.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Explain the aberrant functioning of the immune system at the molecular and cellular levels in cHL and NHL (PMBCL) pathophysiology and recent findings with therapeutic implications;
  • Review the clinical trial data on the safety and efficacy associated with newly approved and emerging treatments for patients with R/R cHL and NHL (PMBCL) and their respective mechanisms of action;
  • Describe best practices for the management of immune checkpoint inhibitor-associated side effects in patients with R/R cHL and NHL (PMBCL).

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.50 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with cHL and NHL.

Credits: 1.50 ANCC Contact Hour(s)

Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.50 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Feel free to pass this invitation on to your physicians, fellows, physician assistants, nurses, pharmacists, healthcare practitioners, and any other colleagues that you believe would be interested in attending this free CME/CNE program.

 

WEBCAST REGISTRATION

Please use the following form to register for this webcast. You will receive an email confirmation shortly after you complete the registration.

If you are unable to register online or do not receive your confirmation email after registering, please email us at support@performedia.com.

Registration Form


*Required field

WEBCAST SIGNIN

Please enter your registered email and click the Sign In button to watch the Live Simulcast.

If you are unable to sign in or watch the live simulcast, please email us at support@performedia.com.

 

 

 

Copyright © 2018 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.